The U.S. may be further into Delta surge than it appears
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
Just how far along into the latest Delta variant-fueled coronavirus surge is the United States? No one knows for sure, but former Food and Drug Administration Commissioner Scott Gottlieb is hopeful the country can "turn a corner" in just two or three weeks, he told CBS News' John Dickerson on Sunday's edition of Face the Nation.
There's a couple of reasons behind the relatively optimistic outlook. For starters, Gottlieb, who has criticized the Centers for Disease Control and Prevention's wide-ranging forecasts for the current wave, believes it's likely there are a lot of mild or subclinical infections in the U.S., which means the number of cases picked up by testing is probably an underestimate of the virus' actual spread. He's also looking across the pond to the United Kingdom, where cases appear to be trending downward again after rising for several weeks. The U.K., Gottlieb noted, has been a few weeks ahead of the U.S. so far and could serve as a sneak preview of the national trajectory.
FiveThirtyEight's Nate Silver also thinks it's worth paying attention to the U.K., as well as India, where the Delta variant originated. Their most recent waves were big ones, but they did appear to turn around quite quickly.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Of course, the U.K. needs to show that it can sustain its recent drop, and either way, the U.S. will likely have a less cohesive path out of the latest wave given the disparate vaccination rates across the country.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Political cartoons for February 7Cartoons Saturday’s political cartoons include an earthquake warning, Washington Post Mortem, and more
-
5 cinematic cartoons about Bezos betting big on 'Melania'Cartoons Artists take on a girlboss, a fetching newspaper, and more
-
The fall of the generals: China’s military purgeIn the Spotlight Xi Jinping’s extraordinary removal of senior general proves that no-one is safe from anti-corruption drive that has investigated millions
-
A Nipah virus outbreak in India has brought back Covid-era surveillanceUnder the radar The disease can spread through animals and humans
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
